Article Details
Retrieved on: 2018-04-18 04:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Soon after the announcement that Thiel—among billionaire ex-hedge fund manager <b>Michael Novogratz</b> and film producer Sam Engelbardt—would be funding the psychedelic trials headed by UK-based company Compass Pathways, a small group of longtime psychedelic researchers began to talk ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here